BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 19073721)

  • 21. CD8+ T Cells Play a Bystander Role in Mice Latently Infected with Herpes Simplex Virus 1.
    Mott KR; Gate D; Matundan HH; Ghiasi YN; Town T; Ghiasi H
    J Virol; 2016 May; 90(10):5059-5067. PubMed ID: 26962220
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bolstering the Number and Function of HSV-1-Specific CD8
    Khan AA; Srivastava R; Chentoufi AA; Kritzer E; Chilukuri S; Garg S; Yu DC; Vahed H; Huang L; Syed SA; Furness JN; Tran TT; Anthony NB; McLaren CE; Sidney J; Sette A; Noelle RJ; BenMohamed L
    J Immunol; 2017 Jul; 199(1):186-203. PubMed ID: 28539429
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gamma interferon can prevent herpes simplex virus type 1 reactivation from latency in sensory neurons.
    Liu T; Khanna KM; Carriere BN; Hendricks RL
    J Virol; 2001 Nov; 75(22):11178-84. PubMed ID: 11602757
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CD8(+) T cells can block herpes simplex virus type 1 (HSV-1) reactivation from latency in sensory neurons.
    Liu T; Khanna KM; Chen X; Fink DJ; Hendricks RL
    J Exp Med; 2000 May; 191(9):1459-66. PubMed ID: 10790421
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Psychological stress compromises CD8+ T cell control of latent herpes simplex virus type 1 infections.
    Freeman ML; Sheridan BS; Bonneau RH; Hendricks RL
    J Immunol; 2007 Jul; 179(1):322-8. PubMed ID: 17579052
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Human Asymptomatic Epitope Peptide/CXCL10-Based Prime/Pull Vaccine Induces Herpes Simplex Virus-Specific Gamma Interferon-Positive CD107
    Khan AA; Srivastava R; Vahed H; Roy S; Walia SS; Kim GJ; Fouladi MA; Yamada T; Ly VT; Lam C; Lou A; Nguyen V; Boldbaatar U; Geertsema R; Fraser NW; BenMohamed L
    J Virol; 2018 Aug; 92(16):. PubMed ID: 29899087
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Medroxyprogesterone acetate inhibits CD8+ T cell viral-specific effector function and induces herpes simplex virus type 1 reactivation.
    Cherpes TL; Busch JL; Sheridan BS; Harvey SA; Hendricks RL
    J Immunol; 2008 Jul; 181(2):969-75. PubMed ID: 18606648
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Level of herpes simplex virus type 1 latency correlates with severity of corneal scarring and exhaustion of CD8+ T cells in trigeminal ganglia of latently infected mice.
    Mott KR; Bresee CJ; Allen SJ; BenMohamed L; Wechsler SL; Ghiasi H
    J Virol; 2009 Mar; 83(5):2246-54. PubMed ID: 19091870
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Increasing antigen presentation on HSV-1-infected cells increases lesion size but does not alter neural infection or latency.
    Russell TA; Velusamy T; Tseng YY; Tscharke DC
    J Gen Virol; 2018 May; 99(5):682-692. PubMed ID: 29620508
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CD8+ T cells patrol HSV-1-infected trigeminal ganglia and prevent viral reactivation.
    St Leger AJ; Hendricks RL
    J Neurovirol; 2011 Dec; 17(6):528-34. PubMed ID: 22161682
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role of CD8+ T cells and lymphoid dendritic cells in protection from ocular herpes simplex virus 1 challenge in immunized mice.
    Matundan H; Mott KR; Ghiasi H
    J Virol; 2014 Jul; 88(14):8016-27. PubMed ID: 24807710
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Influence of galectin-9/Tim-3 interaction on herpes simplex virus-1 latency.
    Reddy PB; Sehrawat S; Suryawanshi A; Rajasagi NK; Mulik S; Hirashima M; Rouse BT
    J Immunol; 2011 Dec; 187(11):5745-55. PubMed ID: 22021615
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Either a CD4(+)or CD8(+)T cell function is sufficient for clearance of infectious virus from trigeminal ganglia and establishment of herpes simplex virus type 1 latency in mice.
    Ghiasi H; Perng G; Nesburn AB; Wechsler SL
    Microb Pathog; 1999 Dec; 27(6):387-94. PubMed ID: 10588911
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A novel HLA (HLA-A*0201) transgenic rabbit model for preclinical evaluation of human CD8+ T cell epitope-based vaccines against ocular herpes.
    Chentoufi AA; Dasgupta G; Christensen ND; Hu J; Choudhury ZS; Azeem A; Jester JV; Nesburn AB; Wechsler SL; BenMohamed L
    J Immunol; 2010 Mar; 184(5):2561-71. PubMed ID: 20124097
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Establishment of latent herpes simplex virus type 1 infection in resistant, sensitive, and immunodeficient mouse strains.
    Ellison AR; Yang L; Voytek C; Margolis TP
    Virology; 2000 Mar; 268(1):17-28. PubMed ID: 10683323
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Infection of BALB/c mice with a herpes simplex virus type 1 recombinant virus expressing IFN-gamma driven by the LAT promoter.
    Ghiasi H; Osorio Y; Hedvat Y; Perng GC; Nesburn AB; Wechsler SL
    Virology; 2002 Oct; 302(1):144-54. PubMed ID: 12429523
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Varicella-zoster virus proteome-wide T-cell screening demonstrates low prevalence of virus-specific CD8 T-cells in latently infected human trigeminal ganglia.
    van Gent M; Ouwendijk WJD; Campbell VL; Laing KJ; Verjans GMGM; Koelle DM
    J Neuroinflammation; 2023 Jun; 20(1):141. PubMed ID: 37308917
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Noncytotoxic lytic granule-mediated CD8+ T cell inhibition of HSV-1 reactivation from neuronal latency.
    Knickelbein JE; Khanna KM; Yee MB; Baty CJ; Kinchington PR; Hendricks RL
    Science; 2008 Oct; 322(5899):268-71. PubMed ID: 18845757
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Human Asymptomatic Epitopes Identified from the Herpes Simplex Virus Tegument Protein VP13/14 (UL47) Preferentially Recall Polyfunctional Effector Memory CD44high CD62Llow CD8+ TEM Cells and Protect Humanized HLA-A*02:01 Transgenic Mice against Ocular Herpesvirus Infection.
    Srivastava R; Khan AA; Garg S; Syed SA; Furness JN; Vahed H; Pham T; Yu HT; Nesburn AB; BenMohamed L
    J Virol; 2017 Jan; 91(2):. PubMed ID: 27847359
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Control of HSV-1 latency in human trigeminal ganglia--current overview.
    Held K; Derfuss T
    J Neurovirol; 2011 Dec; 17(6):518-27. PubMed ID: 22139603
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.